Activated neutrophils release neutrophil extracellular traps (NETs) in response to a variety of
stimuli. NETosis is driven by protein-arginine deiminase type 4, with the release of …

Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that
is under-recognized and difficult to diagnose. Many drugs can cause immune-mediated …

Comprehensive practical guidance for the evaluation and management of patients with drug
allergy and hypersensitivity are lacking. The authors have aimed to create such a document …

Drug-induced immune thrombocytopenia (DITP) is a challenging clinical problem that is
under-recognized, difficult to diagnose and associated with severe bleeding complications …

Many drugs have been implicated in drug-induced immune thrombocytopenia (DITP).
Patients with DITP develop a drop in platelet count 5 to 10 days after drug administration …

Heparin-Induced Thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its
potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis …

Thrombocytopenia is a condition characterized by a decreased number of platelets in
peripheral blood, which can be caused by a myriad of both congenital and acquired …

Thrombocytopenia is a common entity seen in ICU patients and is associated with increased
morbidity such as bleeding and transfusions, and mortality in ICU patients. Various …

Objective: Unusual clinical course Background: The COVID-19 pandemic is a current global
crisis, and there are hundreds of millions of individuals being vaccinated worldwide. At …

COVID-19 is a new disease with many undescribed clinical manifestations. We report herein
a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A …